ACM (Arrhythmogenic cardiomyopathy) & Heart Transplants
ACM Progression & Heart Transplants
Part of the Living with SADS Webinar Series
This webinar is supported in part by an educational grant from StrideBio.
Key Takeaways:
Understand how arrhythmogenic right ventricular cardiomyopathy (ARVC) can progress to end-stage heart failure.
Learn when and why heart transplant evaluation becomes necessary in ARVC patients.
Gain insight into the transplant process, from evaluation through management post-transplant.
Explore the unique challenges faced by ARVC patients in transplant care.
Hear about the latest research and clinical experiences from a specialist in heart failure and ARVC.
Featured Speaker:
Paul Scheel III, MD
Advanced Heart Failure and Transplant Fellow at Johns Hopkins Hospital, Dr. Scheel focuses on the intersection of ARVC and end-stage heart failure, with a special interest in transplant outcomes.